Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NYLI Healthy Hearts ETF HART

The Fund seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the IQ Candriam Healthy Hearts Index The Fund employs a passive management ¿ or indexing ¿ investment approach designed to track the performance of the Underlying Index, which was developed by IndexIQ LLC


ARCA:HART - Post by User

NYLI Healthy Hearts ETF > $19 - Price Target - Potential upside of 100.21%
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(902)
•••
Post by CommonCentsforDollarson Mar 14, 2014 11:05am
180 Views
Post# 22323291

$19 - Price Target - Potential upside of 100.21%

$19 - Price Target - Potential upside of 100.21%

Maxim Group Initiates Coverage on Harvard Apparatus Regenerative Tech (HART)


The firm set a “buy” rating and a $19.00 price target on the stock. Maxim Group’s target price indicates a potential upside of 100.21% from the company’s current price.

https://www.wkrb13.com/markets/279077/maxim-group-initiates-coverage-on-harvard-apparatus-regenerative-tech-hart/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities